StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nuo Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $5.20M, up 166.6% year over year. For fiscal 2025 it was $3.31M, up 142.7% from the year before. Over ten years it grew -8.2% a year on average. The highest annual figure on record is $11.57M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.31M+142.7%
FY2024Dec 31, 2024$1.37M+124.3%
FY2023Dec 31, 2023$608.53K+442.1%
FY2022Dec 31, 2022$112.25K–
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$146.18K-89.3%
FY2018Dec 31, 2018$1.37M+90.1%
FY2017Dec 31, 2017$721.05K-93.7%
FY2015Dec 31, 2015$11.51M+48.3%
FY2014Dec 31, 2014$7.76M-32.9%
FY2013Dec 31, 2013$11.57M+9.5%
FY2012Dec 31, 2012$10.56M+45.8%
FY2011Dec 31, 2011$7.25M+85.3%
FY2010Dec 31, 2010$3.91M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.77M+152.6%
Q1 FY2026Mar 31, 2026$1.30M+168.8%
Q4 FY2025Dec 31, 2025$1.10M+177.8%
Q3 FY2025Sep 30, 2025$1.03M+178.2%
Q2 FY2025Jun 30, 2025$700.20K+92.0%
Q1 FY2025Mar 31, 2025$484.38K+106.5%
Q4 FY2024Dec 31, 2024$394.87K+100.4%
Q3 FY2024Sep 30, 2024$370.95K+59.7%
Q2 FY2024Jun 30, 2024$364.77K+208.7%
Q1 FY2024Mar 31, 2024$234.58K+283.9%
Q4 FY2023Dec 31, 2023$197.02K+166.2%
Q3 FY2023Sep 30, 2023$232.24K+507.2%
Q2 FY2023Jun 30, 2023$118.17K–
Q1 FY2023Mar 31, 2023$61.10K–
Q4 FY2022Dec 31, 2022$74.00K–
Q3 FY2022Sep 30, 2022$38.25K–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$0-100.0%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$4.90K-99.4%
Q3 FY2019Sep 30, 2019$57.88K-77.8%
Q2 FY2019Jun 30, 2019$44.17K-68.1%
Q1 FY2019Mar 31, 2019$39.23K-75.5%
Q4 FY2018Dec 31, 2018$812.06K+311.2%
Q3 FY2018Sep 30, 2018$260.28K+60.5%
Q2 FY2018Jun 30, 2018$138.31K-26.7%
Q1 FY2018Mar 31, 2018$159.94K-7.4%
Q4 FY2017Dec 31, 2017$197.51K+11.7%
Q3 FY2017Sep 30, 2017$162.20K–
Q2 FY2017Jun 30, 2017$188.60K–
Q1 FY2017Mar 31, 2017$172.74K–
Q3 FY2016Sep 30, 2016$176.77K–

More Nuo Therapeutics figures

See a number that looks wrong?